3 ms·
I was also confused about this. The article doesn't discuss any regulatory approval process. Does this treatment somehow fall under one of the categories where
by shkkmo 5y ago
I was also confused about this. The article doesn't discuss any regulatory approval process. Does this treatment somehow fall under one of the categories where that is not required?
- elliekelly 5y agoI think it’s the “Expanded Access Program”[1] they mentioned at the beginning of the article but I struggle to see how that would really apply to autism? [1]https://www.fda.gov/news-events/public-health-focus/expanded-access https://www.fda.gov/news-events/public-health-focus/expanded...